Scientia Vascular develops advanced access products designed to improve simplicity and precision during neurovascular interventions.
Once completed, the acquisition will integrate SPR’s technology into Medtronic’s broader pain management strategy, allowing the company to offer additional options for patients and clinicians seeking alternatives to drug-based therapies.
The integration of the Instinct sensor expands Medtronic’s portfolio of compatible glucose monitoring options, joining two recently introduced alternatives: the Simplera Sync and Guardian 4 sensors.